- Home
- STRO vs NREF Comparison
STRO vs NREF Comparison
Compare STRO & NREF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRO
- NREF
- Stock Information
- Founded
- STRO 2003
- NREF 2019
- Country
- STRO United States
- NREF United States
- Employees
- STRO N/A
- NREF N/A
- Industry
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- NREF Real Estate Investment Trusts
- Sector
- STRO Health Care
- NREF Real Estate
- Exchange
- STRO Nasdaq
- NREF Nasdaq
- Market Cap
- STRO 77.7M
- NREF 244.3M
- IPO Year
- STRO 2018
- NREF 2020
- Fundamental
- Price
- STRO $0.78
- NREF $13.88
- Analyst Decision
- STRO Hold
- NREF Hold
- Analyst Count
- STRO 7
- NREF 3
- Target Price
- STRO $3.97
- NREF $14.50
- AVG Volume (30 Days)
- STRO 1.2M
- NREF 72.6K
- Earning Date
- STRO 08-12-2025
- NREF 07-31-2025
- Dividend Yield
- STRO N/A
- NREF 14.38%
- EPS Growth
- STRO N/A
- NREF N/A
- EPS
- STRO N/A
- NREF 2.59
- Revenue
- STRO $66,434,000.00
- NREF $110,996,000.00
- Revenue This Year
- STRO N/A
- NREF $25.18
- Revenue Next Year
- STRO N/A
- NREF $3.65
- P/E Ratio
- STRO N/A
- NREF $5.38
- Revenue Growth
- STRO N/A
- NREF 370.78
- 52 Week Low
- STRO $0.52
- NREF $12.14
- 52 Week High
- STRO $5.17
- NREF $18.09
- Technical
- Relative Strength Index (RSI)
- STRO 48.21
- NREF 46.31
- Support Level
- STRO $0.73
- NREF $13.64
- Resistance Level
- STRO $0.79
- NREF $14.15
- Average True Range (ATR)
- STRO 0.06
- NREF 0.34
- MACD
- STRO 0.01
- NREF 0.03
- Stochastic Oscillator
- STRO 56.00
- NREF 58.70
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
About NREF NexPoint Real Estate Finance Inc.
NexPoint Real Estate Finance Inc is a real estate investment trust. The company provides structured financing solutions by investing in mid-sized multifamily, storage and select-service, and extended-stay hospitality properties. Its investment objective is to generate attractive, risk-adjusted returns for stockholders over the long term. The Company is focused on originating, structuring and investing in first-lien mortgage loans, mezzanine loans, preferred equity, convertible notes, multifamily properties, and common equity investments, as well as multi-family and single-family rental ("SFR") commercial mortgage-backed securities securitizations ("CMBS securitizations"), multifamily structured credit risk notes ("MSCR Notes") and mortgage-backed securities.